Intro Flashcards
Which type of drug permeation is not governed by Fick’s Law and is capacity limited?
Transport by special carriers
Ionized and polar drugs are more _____ soluble and with ______ clearance
Water soluble
Increased clearance
Absorption is faster with:
_____ surface area and ____ membranes
Larger surface area and thinner membranes
What predicts the rate of movement of molecules across a barrier?
Fick’s law of diffusion
Which quadrant of the buttocks if the safest for IM drugs?
Superolateral
Through which blood vessels do sublingual drugs pass?
Lingual vein– IJV– brachiocephalic– SVC– right atrium
What route has a partial avoidance of the first pass effect?
Rectal
What route offers the closest delivery to the target in respiratory diseases?
Inhalational
Which route of administration is the slowest?
Topical
Arrange topical route from more evaporation to less:
Tincture Wet dressings Lotion Gel Aerosol Powder Paste Cream Foam Ointment
4 factors that determine drug distribution:
Organ size
Blood flow
Solubility
Protein binding
Influences the concentration of the drug in the extracellular fluid surrounding the blood vessel
Solubility
Acidic drugs are bound to this protein
Albumin
Basic drugs bind to this protein
Orosomucoid
A1 acid glycoprotein
What protein binds NT and hormones?
Globulin
Type of drug metabolism where the drugs are metabolized into biologically inactive derivatives
Termination of drug action
Drug metabolism where prodrugs are metabolized to become active
Drug activation
Metabolism:
Some drugs are not modified by the body and continue to act until they are excreted
Elimination without metabolism
Give examples of drugs that undergo elimination without metabolism
Mannitol
Lithium
Electrolytes
Duration of drug action is determined by
Dose administered
Rate of elimination following last dose
This is the most common type of elimination
First order elimination
This type of elimination is proportionate to the concentration
First order elimination
Constant fraction is being eliminated over time
First order elimination
Rate of elimination is constant regardless of concentration
Zero order elimination
Concentration in zero order/saturable/michealis menten decreases ______ over time
Linearly
Drugs that display Zero Order Elimination kinetics?
WHAT PET
Warfarin Heparin Aspirin Tolburamide Phenytoin Ethanol Theophylline
It is the maximal effect available with increasing concentration of a drug
Efficacy (Emax)
It is the dose required to produce 50% of the max effect
Potency (EC50)
Concentration required to bind 50% of the receptors
Kd
Smaller the Kd, the ____ the affinity
Greater
Maximum percentage of receptors with increasing concentration of a drug
Maximal number of receptors bound
Bmax
Minimum dose required to produce a specified response is determined in each member of a population
Quantal Dose-Response Curve
Formula for therapeutic index
TD 50 divided by ED50
Efficacy is measured through _____ dose response curves
Graded
Receptors that do not bind when the drug concentration is sufficient to produce maximal effect
Spare receptors
In the presence of an agonist, a partial agonist can act as _______
Antagonist
Effects of competitive antagonists can be overcome by
Adding more agonist
Competitive antagonists shift the dose response curve to the
Right
Non competitive antagonists causes a ____ shift to the dose response curve
Downward shift
This type of antagonist binds to q different receptor and produces an effect opposite to that produced by the drug it is antagonizing
Physiologic antagonists
This type of antagonist directly interacts with the drug to remove it or prevent it from reaching the target
Chemical antagonist
Responsiveness diminishes rapidly after administration of a drug
Tachyphylaxis
What drugs display tachyphylaxis?
MEDical students Love to watch CNN in HD!
Metoclopramide Ephedrine Dobutamine LSD Calcitonin Nitroglycerin Nicotine Hydralazine Desmopressin
The concentration of a drug at the receptor site
Effective Drug Concentration
The concentration at the receptor site is proportional to the drug concentration in the plasma at equilibrium except in?
Topical agents
Pharmacokinetic parameter that can be altered by liver and kidney disease
Volume of distribution
Clearance
Most important pharmacokinetic parameter to be considered in defining a rational steady state during dose regimen
Clearance
Condition in which the average total amount of drug in the body does not change over multiple dosing intervals
Steady state
Steady state is reached in?
4-5 half lives
Cockroft Gault Equation
72 x serum crea (X 0.85 females)
Long term reduction in receptor number due to continuous exposure to agonist
Downregulation
Receptor activation is blocked for prolonged periods
Upregulation
Fraction of the administered dose that reaches the systemic circulation
Bioavailability
Bioequivalence is determined by
AUC
Cmax
Tmax
This is when the drug is 85-125% of the innovator
Bioequivalence
Pharmacokinetics:
Equal to the rate of elimination arlt steady state
Maintenance dose
This is given when the therapeutic concentration must be achieved rapidly and volume of distribution is large
Loading dose
Formula for adjustment of dose in renal impairment
100ml/min
Computation of the amount of drug in the body at any time:
Vd x plasma concentration
What are the Phase 1 reactions?
HORD
Hydrolysis
Oxidation
Reduction
Deamination
Most important organ for drug metabolism
Liver
Primary determinant of clearance
Drug Biotransformation
Cytochrome P450 INDUCERS:
Ethel Booba takes Phen Phen and Refuses Greasy Carb Shakes
Ethanol Barbiturates Phenytoin Rifampicin Griseofulvin Carbamazepine St. John's Wort
This type of inhibitors bind irreversibly to metabolizing enzymes
Suicide inhibitors
Cytochrome P450 INHIBITORS
Inhibitors Stop Cyber Kids from Eating GRApefruit QV
Isoniazid Sulfinamides Cimetidine Ketoconazole Erythromycin Grapefruit juice Ritonavir Amiodarone Quinidine Valproic acid
These types of Phase 2 reactions are used for inactivation
Acetylation
Methylation
Typical Drugs that use acetylation:
HIPS
Hydralazine
Isoniazid
Procainamide
Sulfonamide
FDA drug category?
Controlled studies in women fail to demonstrate a risk to the fetus in the first trimester. Possibility of fetal harm appears remote
Category A
FDA Category
Either animal reproduction studies have not demonstrated a fetal risk
No controlled studies in PREGNANT WOMEN
Animal studies shown adverse effect but not confirmed in women in 1st trimester
Category B
FDA Category
Studies in animals have revealed adverse effects in fetus and no controlled studies in WOMEN
Or no studies are available
Should be given only when benefit outweighs risk
Category C
FDA category
Positive evidence of human fetal risk but the benefits may be acceptable despite the risk
Category D
FDA Category
Studies in animals or human beings have demonstrated fetal abnormalities
Or there is evidence of fetal risk based on human experience or both
Risk clearly outweighs benefit
Category X
Common Teratogens
Valproic acid
Anti epileptics
Neural tube defects
All anticonvulsants are CYP450 INDUCERS except:
Valproic acid
All antidepressants are CYP450 INHIBITORS except
St. John’s Wort
Teratogen
Phenytoin
Fetal hydantoin syndrome
Teratogen
Diethylstilbestrol (DES)
Vaginal clear cell adenoCA
Teratogen
Lithium
Ebstein’s anomaly
Teratogen
Isotretinoin
Craniofacial malformation
Teratogen
Misoprostol
Möbius sequence
Teratogen
Penicillamine
Cutis laxa
Teratogen
Thalidomide
Phocomelia
Teratogens
Tetracycline
Tooth discoloration
Teratogens
Streptomycin
Ototoxicity
Teratogens
Methimazole
Aplasia cutis congenita
Teratogens
Sulfonamides
Kernicterus
Teratogens
Fluoroquinolones
Cartilage damage
Teratogens
Warfarin 1st trimester
Chondrodysplasia
Teratogens
Warfarin 2nd trimester
CNS malformation
Teratogens
Warfarin 3rd trimester
Bleeding diasthesis
Standard in vitro test for mutagenicity
Uses special strain of Salmonella
Ames Test
In vivo mutagenicity test carried out in mice where males are exposed to substance before mating
Dominant lethal test
Includes all preclinical data collected up to the time of submission and the detailed proposal for clinical trials
Investigational new drug
What clinical trial phase is decribed when there is evaluation of the dose response relationship and pharmacokinetics among NORMAL volunteers?
Phase 1
How many test subjects are included in Phase 1?
25-100 normal
20-50 chemo
Phase of the clinical trial where evaluation of the drug is done in patients with the target disease under controlled conditions.
Phase 2
Phase of clinical trial where desired efficacy at tolerated doses is tested
Phase 2
Phase of the clinical trial where a large design involing many patients that include special populations
Phase 3
Phase of clinical trial where they explore the spectrum further and compare it to older therapies and to discover infrequent toxicities
Phase 3
This is also called the postmarketing surveillance phase
Phase 4
This is the right to market the drug without competition from other firms
Drug patents
How many years is allowed in a drug patent?
20 years